2020 Global Conference on Regulatory Science
October 20-21, 2020 | 10am – 3:30pm ET | Virtual Conference
Thanks everyone who joined us for our first Global Conference on Regulatory Science! For those who could not join, you can view our proceedings above, view the conference recap from HMS for a quick look, or watch the videos below.
Hosted by Harvard-MIT Center for Regulatory Science, the 2020 Global Conference on Regulatory Science convened academic scientists and physicians, international regulators, industry experts and patient groups to explore emerging topics at the intersection between regulatory science and therapeutic development.
The first in an annual series of conferences, a key aim was to advance and sustain a dialogue between academic investigators active in the field and government and industry groups for whom the evaluation, regulation and marketing of medical products is a central concern. The two-day conference included plenary presentations, panel discussions, breakout sessions, and a poster session.
2020 Theme: Machine Learning and Data Science. The conference covered diverse ways in which new computational approaches are integrating preclinical and clinical trial data, real-world evidence, information from electronic devices etc. to change drug development and medical care.
CONFERENCE WORKING GROUPS
Education in Regulatory Science
This working group considered state-of-the-art methods to prepare and continually maintain a workforce equipped to maximize the application of regulatory science to the U.S. Food and Drug Administration’s regulatory activities.
Digital Pathology, AI and Image-Based Biomarkers in Research and Clinical Practice
This workshop covered emerging digital pathology technologies, image-based biomarkers and diagnostics, construction of multiplexed tissue and tumor atlases, use of digital pathology in clinical and research settings, and the regulation of new devices and tests.
Speakers
Adam Palmer, UNC
Amy Abernethy, FDA
Andy Coravos, Elektra Labs
Annie Saha, FDA
Ariel Stern, HBS
Barry Liden, Edwards Lifesciences
Fadia Shaya, UMB
Florence Bourgeois, Harvard-MIT CRS
G Caleb Alexander, JHU
George Daley, HMS
Heidi Dohse, Tour de Heart
Helga Gardarsdottir, Utrecht University
Janet Woodcock, FDA
John Lim, Duke-NUS
Joseph Ross, Yale
Kari Stefansson, deCODE Genetics
Laura Maliszewski, Harvard-MIT CRS
Leslie Wilson, UCSF
Luca Foschini, Evidation Health
Margaret Hamburg, NAM
Mark Namchuk, HMS
Meredith Buxton, GCAR
Michael Rosenblatt, Flagship
Ned Sharpless, NCI
Nilay Shah, Mayo Clinic
Paul Beninger , Tufts
Peter Mol, EMA
Peter Sorger, Harvard-MIT CRS
Raffaella Sadun, HBS
Ray Dorsey, U of Rochester
Sandro Santagata, BWH
Sean Khozin, Janssen
Steve Goodman, Stanford
Steve Galson, Amgen
Timo Minssen, U of Copenhagen